Latest period
$49.5B
YoY change
+3.0%
5Y CAGR
-0.8%
Peak year (FY2015)
$53.2B
Latest annual
$49.5B
Total Equity history chart for Medtronic (MDT) from 2017 to 2026
Latest: $49.5B
Total Equity growth chart for Medtronic (MDT) from 2017 to 2026
Latest: +3.0%
Total Equity history table for Medtronic (MDT) from 1986 to 2026
| FY2026 | $49.5B | +3.0% | +$1.44B | ||
| FY2025 | $48B | -4.4% | -$2.19B | ||
| FY2024 | $50.2B | -2.5% | -$1.27B | ||
| FY2023 | $51.5B | -2.0% | -$1.07B | ||
| FY2022 | $52.6B | +2.2% | +$1.12B | ||
| FY2021 | $51.4B | +1.4% | +$691M | ||
| FY2020 | $50.7B | +1.3% | +$646M | ||
| FY2019 | $50.1B | -1.2% | -$629M | ||
| FY2018 | $50.7B | +0.8% | +$426M | ||
| FY2017 | $50.3B | -3.0% | -$1.53B | ||
| FY2016 | $51.8B | -2.6% | -$1.4B | ||
| FY2015 | $53.2B | +173.8% | +$33.8B | ||
| FY2014 | $19.4B | +4.1% | +$772M | ||
| FY2013 | $18.7B | +9.1% | +$1.56B | ||
| FY2012 | $17.1B | +7.2% | +$1.15B | ||
| FY2011 | $16B | +9.2% | +$1.34B | ||
| FY2010 | $14.6B | +13.8% | +$1.78B | ||
| FY2009 | $12.9B | +11.4% | +$1.32B | ||
| FY2008 | $11.5B | +5.1% | +$559M | ||
| FY2007 | $11B | +17.0% | +$1.59B | ||
| FY2006 | $9.38B | -10.2% | -$1.07B | ||
| FY2005 | $10.4B | +15.1% | +$1.37B | ||
| FY2004 | $9.08B | +14.8% | +$1.17B | ||
| FY2003 | $7.91B | +22.9% | +$1.48B | ||
| FY2002 | $6.43B | +16.7% | +$922M | ||
| FY2001 | $5.51B | +22.7% | +$1.02B | ||
| FY2000 | $4.49B | +19.1% | +$721M | ||
| FY1999 | $3.77B | +84.5% | +$1.73B | ||
| FY1998 | $2.04B | +17.1% | +$298M | ||
| FY1997 | $1.75B | -2.4% | -$43.1M | ||
| FY1996 | $1.79B | +34.0% | +$454M | ||
| FY1995 | $1.34B | +26.7% | +$282M | ||
| FY1994 | $1.05B | +25.2% | +$212M | ||
| FY1993 | $842M | +5.6% | +$45M | ||
| FY1992 | $797M | +16.6% | +$113M | ||
| FY1991 | $683M | +26.3% | +$142M | ||
| FY1990 | $541M | +14.2% | +$67.4M | ||
| FY1989 | $474M | +19.6% | +$77.7M | ||
| FY1988 | $396M | +2.3% | +$8.9M | ||
| FY1987 | $387M | +11.0% | +$38.3M | ||
| FY1986 | $349M | — | — |
- FY2026$49.5B+3.0%
- FY2025$48B-4.4%
- FY2024$50.2B-2.5%
- FY2023$51.5B-2.0%
- FY2022$52.6B+2.2%
- FY2021$51.4B+1.4%
- FY2020$50.7B+1.3%
- FY2019$50.1B-1.2%
- FY2018$50.7B+0.8%
- FY2017$50.3B-3.0%
- FY2016$51.8B-2.6%
- FY2015$53.2B+173.8%
- FY2014$19.4B+4.1%
- FY2013$18.7B+9.1%
- FY2012$17.1B+7.2%
- FY2011$16B+9.2%
- FY2010$14.6B+13.8%
- FY2009$12.9B+11.4%
- FY2008$11.5B+5.1%
- FY2007$11B+17.0%
- FY2006$9.38B-10.2%
- FY2005$10.4B+15.1%
- FY2004$9.08B+14.8%
- FY2003$7.91B+22.9%
- FY2002$6.43B+16.7%
- FY2001$5.51B+22.7%
- FY2000$4.49B+19.1%
- FY1999$3.77B+84.5%
- FY1998$2.04B+17.1%
- FY1997$1.75B-2.4%
- FY1996$1.79B+34.0%
- FY1995$1.34B+26.7%
- FY1994$1.05B+25.2%
- FY1993$842M+5.6%
- FY1992$797M+16.6%
- FY1991$683M+26.3%
- FY1990$541M+14.2%
- FY1989$474M+19.6%
- FY1988$396M+2.3%
- FY1987$387M+11.0%
- FY1986$349M—
Total Equity values are taken from Medtronic's reported balance sheets (interim 6-K and annual 20-F filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Medtronic (MDT)
According to Medtronic's latest reported financial statements, the company's latest reported total equity is $49.5B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
The 2026 reading of Medtronic (MDT) total equity is $49.5B – edged up 3.0% year-over-year.
Medtronic total equity compound annual growth for the 2021–2026 (5 years) window is -0.8%, with a net decline across the window.
Medtronic total equity declined from $53.2B in 2015 to $49.5B in 2026, a 7.1% drawdown.
The highest annual total equity of $53.2B was reported in 2015. The lowest in the available history was $349M in 1986.
Medtronic Total Equity by Year
Medtronic Total Equity 2026: $49.5B
2026's total equity for Medtronic came in at $49.5B, edged up 3.0% from 2025.
Medtronic Total Equity 2025: $48B
Medtronic posted total equity of $48B in 2025, edged down 4.4% below 2024.
Medtronic Total Equity 2024: $50.2B
In 2024, Medtronic reported total equity of $50.2B, edged down 2.5% below 2023.
Medtronic Total Equity 2023: $51.5B
Medtronic total equity in 2023 was $51.5B, edged down 2.0% below 2022.
Medtronic Total Equity 2022: $52.6B
Medtronic total equity in 2022 was $52.6B.
See more financial history for Medtronic (MDT).
Sector peers by Total Equity
Healthcare peers of Medtronic (MDT), ranked by their latest total equity
| $94.1B | |
| $81.5B | |
| $53.4B | |
| $52.6B | |
| $30.5B | |
| $26.5B | |
| $8.66B | |
| -$3.27B |
- $94.1B
- $81.5B
- $52.6B
- $30.5B
- $26.5B
- $8.66B
- -$3.27B
Frequently asked questions
Medtronic (MDT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.97% TTM
- Dividend Profile3.48% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History7 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.